The statement, published online in the European Heart Journal (25th April 2013, doi: 10.1093/eurheartj/eht154), is written by a committee led by Dr Felix Mahfoud (Saarland University, Saar, Germany). They state that the data support the concept that radiofrequency ablation of the renal nerves reduces blood pressure and improves blood-pressure control in these difficult-to-treat patients, with results now extending to 36 months.
The statement also reviews the appropriate screening measures necessary to select patients eligible for renal denervation. These are:
office-based blood pressure >160 mmHg (>150 mmHg in patients with type 2 diab